Dr. Resneck is the Bruce U. Wintroub Endowed Professor and Chair of the UCSF Department of Dermatology, and holds a joint appointment as an affiliated faculty member at the Philip R. Lee Institute for Health Policy Studies. In earlier roles, Dr. Resneck served as residency training director and then medical director for dermatology at UCSF.
Dr. Resneck became president of the American Medical Association in June 2022. He is a passionate advocate for physicians and patients, a prominent spokesperson for innovation, and a champion for a more equitable health care system. Whether testifying before Congress about removing dysfunction from health care, caring for his patients at UCSF, or advocating for physician values in emerging technology, Dr. Resneck channels his leadership to improve the lives of patients and the working environment for America’s physicians to help build stronger, healthier communities.
Dr. Resneck was elected to the American Medical Association Board of Trustees in 2014 and served as its chair from 2018 to 2019. He is a former member of the board of the American Academy of Dermatology and the former president of the California Society for Dermatology and Dermatologic Surgery. Currently, he is a member of the editorial board of the Journal of the American Academy of Dermatology and serves on the board of directors for the National Quality Forum. He is active in health services research, and his studies on patient access to care, health care delivery, telemedicine and public health have been published in prominent journals and attracted national media attention. He is a sought-after speaker and has given dozens of invited lectureships around the country.
Dr. Resneck’s leadership is collaborative, inclusive, focused and infused with purpose. This is evident whether he is engaging the AMA’s Litigation Center to protect physicians’ free speech and fight societal discrimination against marginalized patients—or advocating on Capitol Hill for fair Medicare payment systems, improved patient access to care, lower prescription drug prices, and reduced dysfunction and burdens in health care.
Raised in Louisiana, Dr. Resneck received his BA in public policy from Brown University and his MD from UCSF—where he also completed his internship in internal medicine, residency in dermatology and fellowship in health policy.